Inception Fertility launches state-of-the-art long-term storage solution for reproductive tissue cryopreservation

0

HavenCryo goes beyond industry standards to provide unique options for practices, future parents and those who have completed their assisted reproduction therapies

HOUSTON, June 2, 2022 /PRNewswire/ — Inception Fertility™ (Inception), a family of brands that touches every stage of the fertility lifecycle, has expanded its ecosystem to include the launch of HavenCryo™, a long-term storage solution for reproductive tissue and cryopreservation that offers a unique experience for fertility providers and patients.

Developed by renowned scientists and leaders in long-term cryostorage of reproductive tissues, HavenCryo offers the most advanced cryopreservation available, combined with state-of-the-art storage equipment and state-of-the-art security technologies, allowing patients to store their tissues breeders for as long as they need. HavenCryo’s unique level of security includes its geographic location, which is strategically based in San Antonio, TX due to the environmental safety of the area and the low risk of interference from natural disasters.

HavenCryo builds on Inception’s commitment to helping aspiring parents start their families when the time is right by storing reproductive tissues, including oocytes (eggs), sperm and embryos, for an indefinite period of time, giving patients more flexibility for family building, peace of mind and control over their reproductive choices. Unique to industry standards, HavenCryo also gives clients who are at the end of their assisted reproduction therapies the ability to store reproductive tissue for as long as they wish.

HavenCryo’s first customers are TJ and Margaret Farnsworth. Farnsworth is the founder and CEO of Inception, which he launched after a two-year infertility journey that left the couple eager to improve the patient experience for aspiring parents-to-be. Since launching Inception in 2014, the company has become the largest provider of fertility services in North Americaand it offers patients everything from diagnostics and treatments to affordability and now to long-term storage solutions.

For fertility clinics, HavenCryo allows them to focus on the most important part of the reproductive journey: patient care. With a centralized location and advanced transport and cryopreservation protocols, HavenCryo’s experienced staff streamline safe and timely transfers, while its cutting-edge technologies improve the preservation process for patients planning their future.

“Inception Fertility is thrilled to launch another brand that gives people more control over their fertility through safe and reliable options that are powered by cutting-edge technologies that will deliver optimal results,” said TJ Farnsworth, Founder and CEO of Inception Fertility. “HavenCryo goes beyond patient needs and empowers clinicians to focus their efforts and expertise on delivering exceptional patient care.”

Clinicians and patients interested in learning more about their long-term reproductive storage options and how HavenCryo can meet their needs can visit www.havencryo.com

About HavenCryo

A provider of long-term reproduction preservation and storage solutions, HavenCryo™ is built on a foundation of advanced techniques, state-of-the-art security and dual-monitoring technology, and world-renowned expertise.

Developed by world-renowned experts in fertility and long-term reproductive preservation, HavenCryo’s mission is to provide peace of mind at every step of the fertility preservation journey, from safe and timely transport to long-term secure storage.

About Initial Fertility

Initial fertility (Inception) is a family of fertility brands committed to helping patients build families of their own. Built by patients for patients, Inception’s purpose is to set the highest bar in experience, science and medicine with the goal of improving every patient’s experience and achieving best results.

Inception’s medical experts are pioneers in fertility care. Our doctors are among the first to use breakthrough assisted reproductive technologies (ART) – including in vitro fertilization (IVF), pregenetic implantation testing (PGT) and fertility preservation services – and they continue to lead the industry in leveraging these technologies through development, research and thought leadership.

Its growing family of national organizations is an ecosystem of care, touching every step of the fertility journey, including diagnosis and treatment to affordability. Through this unique ecosystem, Inception strives to deliver on its promise to push the boundaries of what is possible to exceed patient expectations.

MEDIA CONTACT:
Mia Humphreys
Krupp
239-297-6592
kruppagency.com

SOURCE Inception Fertility

Share.

Comments are closed.